ArticleBMC urology2024

Evaluation of serum fibronectin levels and fibronectin gene polymorphism in patients receiving intravesical BCG therapy for non-muscle invasive bladder cancer and its prognostic value.

Ali Nebioğlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.